Quality assurance and risk reduction guidelines

Acta Cytologica

Volumn 44, Issue 4, 2000, Pages 496-507

  Mody, D R ^a   Davey, D D ^a   Branca, M ^a   Raab, S S ^a   Schenck, U G ^a   Stanley, M W ^a   Wright, R G ^a   Arbyn, M ^a   Beccati, D ^a   Bishop, J W ^a   Martins Collaco, L ^a   Cramer, S F ^a   Fitzgerald, P ^a   Heinrich, J ^a   Jhala, N C ^a   Montanari, G ^a   Kapila, K ^a   Naryshkin, S ^a   Suprun, H Z ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cervix neoplasms; Mass screening; Papanicolaou smear

Indexed keywords

COLPOSCOPY; CYTOLOGY; CYTOPATHOLOGY; MASS SCREENING; MONITORING; PAPANICOLAOU TEST; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK MANAGEMENT; SCREENING; UTERINE CERVIX TUMOR;

EID: 0033900080     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000328521     Document Type: Review

References (46)

1. Increased detection of epithelial cell abnormality by liquid-based gynecologic cytology preparations: A review of accumulated data
2. Rapid cervical cytology screening
3. Statistical quality assurance in cytology: The use of the Pathfinder(TM) to continuously assess screener process control in real time
4. Reliability and accuracy in reporting CIN in 14 laboratories: Developing new indices of diagnostic variability in an interlaboratory study
5. Cost effectiveness of three new technologies to evaluate the sensitivity value of Pap testing
6. Bundesarztekammer: Leitlinie der Bundesarztekammer zur Qualitatssicherung zytologischer Untersuchungen im Rahmen der Fruherkennung des Zervixkarzinoms
7. Interlaboratory reproducibility in reporting inadequate cervical-smears: A multicentric multinational study
8. External quality assurance in cervical vaginal cytology: International agreement in the Emilia Romagna region of Italy
9. European guidelines for quality assurance in cervical cancer screening
10. Internal quality control for cervical cytopathology laboratories
11. Quality assurance in the cytology laboratory
12. Papanicolaou smear 5-year retrospective review: What is required by CLIA '88
13. Quality improvement in gynecologic cytology
14. Epithelial cells and specimen adequacy: Current practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
15. Rapid rescreening smears: An improved method of quality control
16. Rapid review (partial rescreening) of cervical cytology: Four years experience and quality assurance implications
17. Evaluation of proficiency testing as a method of assessing competence to screen cervical smears
18. Rescreening in Gynecologic Cytology: Rescreening of 3762 previous cases for current high-grade squamous intraepithelial lesions and carcinoma: A CAP Q Probes study of 312 institutions
19. Quality management in gynecologic cytology using interlaboratory comparison
20. Kassenarztliche Bundesvereinigung: Neufassung der Qualitatsvoraussetzungen in der Gynakologischen Zytologie
21. A practical guide to Papanicolaou smear rescreens: How many slides must be reevaluated to make a statistically valid assessment of screening performance?
22. Quality assurance/control issues: IAC Task Force Summary
23. Quality assurance in cervical screening in the United Kingdom
24. Cytopathology laboratory improvement programs of the College of American Pathologists: Laboratory Accreditation Program (CAP LAP) and Performance Improvement Program in Cervicovaginal Cytology (CAP PAP)
25. A quality control system involving peer review of abnormal cervical smears
26. Investigation of the visual cytoscreening of conventional gynecologic smears: II. Analysis of eye movement
27. Terminology: IAC Task Force Summary
28. Quality assurance by continuous recording of the microscope status
29. Workload in the cytology laboratory
30. Investigation of the visual cytoscreening of conventional gynecologic smears: I. Analysis of slide movement
31. Quality assurance in the cytopathology laboratories of the Finnish Cancer Society
32. Evaluation of 5-year review of negative cervical smears in patients with high-grade squamous intraepithelial lesions
33. Evaluation of 10% rescreen of negative gynecologic smears as a quality assurance measure
34. Opinion pool on quality assurance and quality control
35. Parameters of quality control in cervical cytodiagnostic